These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8944046)

  • 1. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Comparison with ordinary hodgkin's disease.
    Bellas C; Santón A; Manzanal A; Campo E; Martin C; Acevedo A; Varona C; Forteza J; Morente M; Montalbán C
    Am J Surg Pathol; 1996 Dec; 20(12):1520-4. PubMed ID: 8944046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions within the epstein-barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin's disease.
    Santón A; Bellas C
    Leuk Lymphoma; 2001 Jan; 40(3-4):235-42. PubMed ID: 11426545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
    Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
    Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease.
    Santón A; Manzanal AI; Campo E; Bellas C
    Clin Mol Pathol; 1995 Aug; 48(4):M184-7. PubMed ID: 16696002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
    Audouin J; Diebold J; Pallesen G
    J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus.
    Siebert JD; Ambinder RF; Napoli VM; Quintanilla-Martinez L; Banks PM; Gulley ML
    Hum Pathol; 1995 Nov; 26(11):1191-5. PubMed ID: 7590691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
    Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections.
    Santón A; Martín C; Manzanal AI; Preciado MV; Bellas C
    Br J Haematol; 1998 Oct; 103(1):129-36. PubMed ID: 9792299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of association of Epstein Barr-virus with Hodgkin's disease.
    Radha K; Shanthi P; Madhavan M; Senthamarai A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
    Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
    Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
    Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
    Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
    Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
    Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
    Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
    Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Epstein-Barr virus markers in Reed-Sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country.
    Belkaid MI; Brière J; Djebbara Z; Beldjord K; Andrieu JM; Colonna P
    Leuk Lymphoma; 1995 Mar; 17(1-2):163-8. PubMed ID: 7773154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.